Université de Montréal gains access to ERS Genomics’ CRISPR/Cas9 patents, launching platforms for genome-wide screening and fostering research collaborations.
Université de Montréal gains access to ERS Genomics’ CRISPR/Cas9 patents, launching platforms for genome-wide screening and fostering research collaborations.